双动全髋关节置换术在假体周围髋关节感染二期翻修后行近端股骨置换的脱位与翻修风险
本研究回顾性分析2010至2017年单中心70例因慢性髋关节假体周围感染行二期翻修、并采用双动髋臼假体联合近端股骨置换或全股骨置换的患者。5年脱位风险为17%,脱位翻修风险为12%,全因假体翻修风险为20%。全股骨置换患者脱位风险显著高于近端股骨置换患者(亚风险比3.9)。
要点
- 二期翻修后近端股骨置换联合双动髋臼假体的5年脱位风险为17%,脱位翻修风险为12%。
- 全股骨置换患者脱位风险(亚风险比3.9)和脱位翻修风险(亚风险比4.4)均高于近端股骨置换患者。
- 5年全因假体翻修风险为20%,再感染翻修占23%,假体周围骨折行柄翻修占3%。
核心结论
- 尽管双动轴承可能是降低翻修全髋关节置换脱位风险的直观选择,但二期翻修后近端股骨置换仍存在相当的脱位风险,尤其是全股骨置换患者。
- 作者认为未来研究应比较三极约束植入物与非约束双动髋臼杯在近端股骨置换患者中降低不稳风险的表现。
研究设计与样本
- 本研究为单学术中心回顾性研究,纳入2010至2017年期间因慢性髋关节假体周围感染行二期翻修的患者。
- 研究期间共220例患者行二期翻修,其中33%(73/220)因股骨骨缺损行单一设计模块化肿瘤型近端股骨置换并采用骨水泥柄。
- 73例中4%(3/73)因挽救感染性鞍状假体而行双极半髋置换,余70例采用双动髋臼假体联合近端股骨置换(84%[59/70])或全股骨置换(16%[11/70])。
- 患者中位年龄73岁(四分位距63至79岁),女性占60%(42/70),平均随访50±25个月。
- 研究采用竞争风险分析(以死亡为竞争事件)计算翻修和脱位风险,并提供95%置信区间;采用Fine和Gray模型计算亚风险比。
主要发现
- 采用双动髋臼假体行二期翻修的患者5年脱位风险为17%(95%CI 9%至32%),脱位翻修风险为12%(95%CI 5%至24%)。
- 5年全因假体翻修风险为20%(95%CI 12%至33%)。
- 23%(16/70)患者因再感染行翻修手术,3%(2/70)患者因创伤性假体周围骨折行柄翻修,无患者因无菌性松动行翻修。
- 全股骨置换患者发生脱位的可能性高于近端股骨置换患者(亚风险比3.9[95%CI 1.1至13.3];p=0.03),脱位翻修的可能性也更高(亚风险比4.4[95%CI 1至18.5];p=0.04)。
- 在现有样本量下,未发现脱位患者在患者相关因素、手术相关因素或髋臼假体位置方面存在差异。
关键数值与推荐
- 5年脱位风险17%(95%CI 9%至32%),5年脱位翻修风险12%(95%CI 5%至24%)。
- 5年全因假体翻修风险20%(95%CI 12%至33%)。
- 全股骨置换与近端股骨置换相比,脱位亚风险比3.9(95%CI 1.1至13.3;p=0.03),脱位翻修亚风险比4.4(95%CI 1至18.5;p=0.04)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dislocation is a major complication of revision THA after two-stage exchange for periprosthetic joint infection (PJI). The likelihood of dislocation can be particularly high if megaprosthetic proximal femoral replacement (PFR) has been performed during a second-stage reimplantation. Dual-mobility acetabular components are an established way of reducing the instability risk in revision THA; however, the likelihood of dislocation for dual-mobility reconstructions in the setting of a two-stage PFR has not been studied systematically, although patients with these reconstructions might be at an increased risk. QUESTIONS/PURPOSES: (1) What is the risk of dislocation and revision for dislocation in patients who underwent PFR with a dual-mobility acetabular component as part of two-stage exchange for hip PJI? (2) What is the risk of all-cause implant revision and what other procedures were performed (apart from revision for a dislocation) in these patients? (3) What potential patient-related and procedure-related factors are associated with dislocation? METHODS: This was a retrospective study from a single academic center including procedures performed between 2010 and 2017. During the study period, 220 patients underwent two-stage revision for chronic hip PJI. Two-stage revision was the approach of choice for chronic infections, and we did not perform single-stage revisions for this indication during the study period. Thirty-three percent (73 of 220) of patients underwent second-stage reconstruction with a single-design, modular, megaprosthetic PFR because of femoral bone loss, using a cemented stem. A cemented dual-mobility cup was the approach of choice for acetabular reconstruction in the presence of a PFR; however, 4% (three of 73) were reconstructed with a bipolar hemiarthroplasty to salvage an infected saddle prosthesis, leaving 70 patients with a dual-mobility acetabular component and a PFR (84% [59 of 70]) or total femoral replacement (16% [11 of 70]). We used two similar designs of an unconstrained cemented dual-mobility cup during the study period. The median (interquartile range) patient age was 73 years (63 to 79 years), and 60% (42 of 70) of patients were women. The mean follow-up period was 50 ± 25 months with a minimum follow-up of 24 months for patients who did not undergo revision surgery or died (during the study period, 10% [seven of 70] died before 2 years). We recorded patient-related and surgery-related details from the electronic patient records and investigated all revision procedures performed until December 2021. Patients who underwent closed reduction for dislocation were included. Radiographic measurements of cup positioning were performed using supine AP radiographs obtained within the first 2 weeks after surgery using an established digital method. We calculated the risk for revision and dislocation using a competing-risk analysis with death as a competing event, providing 95% confidence intervals. Differences in dislocation and revision risks were assessed with Fine and Gray models providing subhazard ratios. All p values were two sided and the p value for significance was set at 0.05. RESULTS: The risk of dislocation (using a competing-risks survivorship estimator) was 17% (95% CI 9% to 32%) at 5 years, and the risk of revision for dislocation was 12% (95% CI 5% to 24%) at 5 years among patients treated with dual-mobility acetabular components as part of a two-stage revision for PJI of the hip. The risk of all-cause implant revision (using a competing-risk estimator, except for dislocation) was 20% (95% CI 12% to 33%) after 5 years. Twenty-three percent (16 of 70) of patients underwent revision surgery for reinfection and 3% (two of 70) of patients underwent stem exchange for a traumatic periprosthetic fracture. No patients underwent revision for aseptic loosening. We found no differences in patient-related and procedure-related factors or acetabular component positioning for patients with dislocation with the numbers available; however, patients with total femoral replacements had a higher likelihood of dislocation (subhazard ratio 3.9 [95% CI 1.1 to 13.3]; p = 0.03) and revision for a dislocation (subhazard ratio 4.4 [95% CI 1 to 18.5]; p = 0.04) than those who received PFR. CONCLUSION: Although dual-mobility bearings might be an intuitive potential choice to reduce the dislocation risk in revision THA, there is a considerable dislocation risk for PFR after two-stage surgery for PJI, particularly in patients with total femoral replacements. Although the use of an additional constraint might appear tempting, published results vary tremendously, and future studies should compare the performance of tripolar constrained implants to that of unconstrained dual-mobility cups in patients with PFR to reduce the risk of instability. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Theil C, Schwarze J, Smolle MA, et al. What Is the Risk of Dislocation and Revision in Proximal Femoral Replacement with Dual-mobility Articulation After Two-stage Revision for Periprosthetic Hip Infection? Clin Orthop Relat Res. 2023. PMID: 36897193. doi:10.1097/CORR.0000000000002623
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。